Black men with localized prostate cancer who had been treated with definitive radiotherapy had a lower likelihood of experiencing biochemical recurrence, distant metastasis, and prostate cancer–specific mortality compared with White men despite having more aggressive disease, according to findings from a meta-analysis that were published in JAMA Network Open.1
The results showed that Black men had a lower risk of biochemical recurrence (subdistribution hazard ratios [sHR], 0.88; 95% CI, 0.58-0.91), distant metastasis (sHR, 0.72; 95% CI, 0.58-0.91), and prostate cancer–specific mortality (sHR, 0.72; 95% CI, 0.54-0.97) vs White men.
“The findings of this meta-analysis suggest that Black men enrolled in randomized clinical trials present with more aggressive disease but have better biochemical recurrence, distant metastasis, and prostate cancer–specif
Read Full Article at www.onclive.com
